Related Experiment Video
Updated: Jun 30, 2026

Expansion of Two-dimension Electrospun Nanofiber Mats into Three-dimension Scaffolds
Published on: January 7, 2019
MXene-based biomaterial nanoarchitectonics for chronic wound healing
Lufeng Yao1, Guodun Zheng2, Jin Cao3
1Department of Foot and Ankle Surgery, Ningbo No.6 Hospital, Ningbo 315040, Zhejiang, China.
Background:
Chronic wounds impose a severe global clinical burden, affecting millions of patients yearly and causing substantial healthcare costs. Commercial dressings are limited by single-functionality. They cannot address core pathological barriers: persistent infection, prolonged inflammation, insufficient angiogenesis, and impaired electrophysiology. MXene, an emerging two-dimensional nanoarchitectonic material, has distinctive physicochemical properties (high conductivity, efficient photothermal conversion, versatile surface modifiability). It promotes chronic wound healing via four synergistic core mechanisms: antibacterial action, anti-inflammatory effects, pro-angiogenic capacity, and electrical sensing. However, systematic summaries integrating its synthesis, modification, mechanisms, and clinical prospects in chronic wound healing are lacking.
Aim Of Review:
This review aims to fill the existing knowledge gap. It comprehensively organizes the latest research progress, core therapeutic mechanisms, and application potential of MXene-based biomaterials in chronic wound healing. It also provides theoretical and technical support for rational advanced multifunctional wound dressing design and clinical translation.
Key Scientific Concepts Of Review:
MXene has a well-defined structure-performance-biological effect correlation, underpinning its unique multifunctional synergy. This synergy significantly outperforms single-functional commercial dressings. Recent advances in MXene's synthesis/modification strategies and composite biomaterials (hydrogels, nanofibrous membranes, microneedles) have enhanced its therapeutic efficacy. Core challenges restricting clinical translation include oxidation instability, high large-scale production costs, and unconfirmed long-term biosafety. Targeted future research directions (e.g., fluorine-free synthesis, stability modification) are proposed to address these critical issues.

